Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders
Javier Fernández‐Ruíz, Mariluz Hernández, J.A. Ramos
CNS Neuroscience & Therapeutics (2010) Vol. 16, Iss. 3
Open Access | Times Cited: 154

Showing 1-25 of 154 citing articles:

The Role of Dopamine in Schizophrenia from a Neurobiological and Evolutionary Perspective: Old Fashioned, but Still in Vogue
Ralf Brisch, Arthur Saniotis, Rainer Wolf, et al.
Frontiers in Psychiatry (2014) Vol. 5
Open Access | Times Cited: 482
The effects of Δ9-tetrahydrocannabinol on the dopamine system
Michael Bloomfield, Hulegar A. Abhishekh, Nora D. Volkow, et al.
Nature (2016) Vol. 539, Iss. 7629, pp. 369-377
Open Access | Times Cited: 301
Effects of endocannabinoid system modulation on cognitive and emotional behavior
Claudio Zanettini
Frontiers in Behavioral Neuroscience (2011) Vol. 5
Open Access | Times Cited: 197
Cannabinoid and opioid interactions: Implications for opiate dependence and withdrawal
Jillian L. Scavone, Robert C. Sterling, Elisabeth J. Van Bockstaele
Neuroscience (2013) Vol. 248, pp. 637-654
Open Access | Times Cited: 185
Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine
Laura E. Halpin, Stuart A. Collins, Bryan K. Yamamoto
Life Sciences (2013) Vol. 97, Iss. 1, pp. 37-44
Open Access | Times Cited: 185
Dopaminergic Neurotransmission in the Nucleus Accumbens Modulates Social Play Behavior in Rats
Antonia Manduca, Michela Servadio, Ruth Damsteegt, et al.
Neuropsychopharmacology (2016) Vol. 41, Iss. 9, pp. 2215-2223
Open Access | Times Cited: 132
Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy
Marı́a José Casarejos, Juan Perucho, Ana Gómez, et al.
Journal of Alzheimer s Disease (2013) Vol. 35, Iss. 3, pp. 525-539
Open Access | Times Cited: 122
Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies
Befort Katia
Frontiers in Pharmacology (2015) Vol. 6
Open Access | Times Cited: 112
Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease
Felipe Patricio, Alan Axel Morales-Andrade, Aleidy Patricio-Martínez, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 96
Cannabinoid–dopamine interactions in the physiology and physiopathology of the basal ganglia
Concepción García, Cristina Palomo‐Garo, Yolanda Gómez‐Gálvez, et al.
British Journal of Pharmacology (2015) Vol. 173, Iss. 13, pp. 2069-2079
Open Access | Times Cited: 94
Acute memory and psychotomimetic effects of cannabis and tobacco both ‘joint’ and individually: a placebo-controlled trial
Chandni Hindocha, Tom P. Freeman, Joanna Xia, et al.
Psychological Medicine (2017) Vol. 47, Iss. 15, pp. 2708-2719
Open Access | Times Cited: 92
Cannabinoids in Parkinson's Disease
Mario Stampanoni Bassi, Andrea Sancesario, Roberta Morace, et al.
Cannabis and Cannabinoid Research (2017) Vol. 2, Iss. 1, pp. 21-29
Open Access | Times Cited: 89
Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways
Oscar Gómez, Aminael Sánchez‐Rodríguez, MQU Le, et al.
British Journal of Pharmacology (2011) Vol. 163, Iss. 7, pp. 1520-1532
Open Access | Times Cited: 110
Comorbid substance use disorder in schizophrenia: A selective overview of neurobiological and cognitive underpinnings
Patrizia Thoma, Irene Daum
Psychiatry and Clinical Neurosciences (2013) Vol. 67, Iss. 6, pp. 367-383
Open Access | Times Cited: 94
The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study
Michael Bloomfield, Celia J. A. Morgan, Shitij Kapur, et al.
Psychopharmacology (2014) Vol. 231, Iss. 11, pp. 2251-2259
Closed Access | Times Cited: 91
Beyond Pharmacotherapy: Understanding the Links between Obesity and Chronic Mental Illness
Valerie H. Taylor, Roger S. McIntyre, Gary Remington, et al.
The Canadian Journal of Psychiatry (2012) Vol. 57, Iss. 1, pp. 5-12
Open Access | Times Cited: 90
TRPs in the Brain
Rudi Vennekens, Aurélie Menigoz, Bernd Nilius
Springer eBooks (2012), pp. 27-64
Closed Access | Times Cited: 89
Individual differences in response to positive and negative stimuli: endocannabinoid-based insight on approach and avoidance behaviors
Daniela Laricchiuta, Laura Petrosini
Frontiers in Systems Neuroscience (2014) Vol. 8
Open Access | Times Cited: 68
Effects of Pubertal Cannabinoid Administration on Attentional Set-Shifting and Dopaminergic Hyper-Responsivity in a Developmental Disruption Model of Schizophrenia
Felipe V. Gomes, Francisco Silveira Guimarães, Anthony A. Grace
The International Journal of Neuropsychopharmacology (2015) Vol. 18, Iss. 2
Open Access | Times Cited: 67
Type-2 cannabinoid receptors in neurodegeneration
Tiziana Bisogno, Sergio Oddi, Alessandra Piccoli, et al.
Pharmacological Research (2016) Vol. 111, pp. 721-730
Closed Access | Times Cited: 66
Hub and switches: endocannabinoid signalling in midbrain dopamine neurons
Miriam Melis, Marco Pistis
Philosophical Transactions of the Royal Society B Biological Sciences (2012) Vol. 367, Iss. 1607, pp. 3276-3285
Open Access | Times Cited: 73
Simultaneous analysis of synthetic cannabinoids in the materials seized during drug trafficking using GC-MS
Hyeyoung Choi, Sewoong Heo, Sanggil Choe, et al.
Analytical and Bioanalytical Chemistry (2012) Vol. 405, Iss. 12, pp. 3937-3944
Closed Access | Times Cited: 70
Cannabis-Related Working Memory Deficits and Associated Subcortical Morphological Differences in Healthy Individuals and Schizophrenia Subjects
Matthew J. Smith, Derin Cobia, Lei Wang, et al.
Schizophrenia Bulletin (2013) Vol. 40, Iss. 2, pp. 287-299
Open Access | Times Cited: 69
Chronic Adolescent Exposure to Delta-9-Tetrahydrocannabinol in COMT Mutant Mice: Impact on Indices of Dopaminergic, Endocannabinoid and GABAergic Pathways
Áine Behan, Magdalena Hryniewiecka, Colm O’Tuathaigh, et al.
Neuropsychopharmacology (2012) Vol. 37, Iss. 7, pp. 1773-1783
Open Access | Times Cited: 68
The genetic basis of the endocannabinoid system and drug addiction in humans
José Antonio López‐Moreno, Víctor Echeverry‐Alzate, Kora‐Mareen Bühler
Journal of Psychopharmacology (2011) Vol. 26, Iss. 1, pp. 133-143
Closed Access | Times Cited: 66
Page 1 - Next Page

Scroll to top